Literature DB >> 3470172

Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.

C Fucini, S M Tommasi, S Rosi, G Malatantis, G Cardona, S Panichi, U Bettini.   

Abstract

Sixty-four consecutive patients who had undergone curative resection for colorectal carcinoma were studied prospectively to evaluate the roles of sequential CEA determinations and independent instrumental follow-up in the early detection of resectable recurrences. Fifty-two of these patients also were submitted to sequential determinations of other tumor antigens: TPA (tissue polypeptide antigen) and Ca 19-9 (colon cancer antigen detected with a monoclonal antibody), for a retrospective evaluation of their utility as markers of recurrent tumors. Twenty-two recurrences were detected in a period ranging from 12 to 72 months (median, 47 months). CEA was the best predictor of recurrence (sensitivity, 90 percent) when compared with the other two markers (TPA sensitivity, 60 percent; Ca 19-9 sensitivity, 20 percent). When compared with the instrumental or biochemical examinations of the follow-up, CEA was still the most sensitive indicator of relapse although the specificity was quite low (78 percent) if minimal significative increases were considered. History and physical examination were more useful than CEA in detecting local recurrences in rectal cancer where the preoperative CEA level was low. A few second-look explorations based solely on small CEA increases failed to demonstrate recurrence or revealed peritoneal carcinomatosis. Selected second-look surgery based on demonstrated recurrences resulted in a resectability rate of 57 percent. A follow-up program based on frequent CEA assays, history, and physical examinations, including rectal, vaginal, and perineal exploration, is proposed. Extensive instrumental investigations should follow when a minimal significative CEA rise is observed, or when history and physical examinations suggest a possible recurrence. Second-look surgery should be evaluated after confirmed or highly suspected diagnosis of recurrence, on the basis of instrumental or clinical examinations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470172     DOI: 10.1007/BF02556172

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

Authors:  C X Zheng; W H Zhan; J Z Zhao; D Zheng; D P Wang; Y L He; Z Q Zheng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Authors:  Wesam A Nasif; Mahmoud Lotfy; Ibrahim H El-Sayed; Ayman El-Meghawry El-Kenawy; Mohamed El-Shahat; Nabil Gad El-Hak
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 3.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 4.  The use and potential of serum tumour markers, new and old.

Authors:  S E Bates
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

5.  The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer.

Authors:  P Barillari; G Ramacciato; R de Angelis; P Gozzo; P Aurello; M Indinnimeo; S Valabrega; F D'Angelo; G Fegiz
Journal:  Int J Colorectal Dis       Date:  1989-12       Impact factor: 2.571

6.  Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?

Authors:  Fatih Selcukbiricik; Ahmet Bilici; Deniz Tural; Sibel Erdamar; Ozlem Soyluk; Evin Buyukunal; Fuat Demirelli; Suheyla Serdengecti
Journal:  Tumour Biol       Date:  2013-04-28

7.  Surgery for recurrent colorectal carcinoma--is it worthwhile?

Authors:  S G Pollard; R Macfarlane; W G Everett
Journal:  Ann R Coll Surg Engl       Date:  1989-09       Impact factor: 1.891

8.  Follow-up recommendations for colon cancer.

Authors:  W Donald Buie; Jo-Anne P Attard
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Radioimmuno-guided endoscopy (RIGE) in the detection of primary and recurrent rectal tumor.

Authors:  U Prati; L Roveda; R Butera; S Nazari; E Trespi; C Aprile; A Zonta
Journal:  Int J Colorectal Dis       Date:  1992-09       Impact factor: 2.571

10.  Colorectal carcinoma with extremely low CA19-9.

Authors:  Yutaka J Kawamura; Aika Tokumitsu; Junichi Sasaki; Shingo Tsujinaka; Takafumi Maeda; Ken Mizogami; Fumio Konishi
Journal:  Gastroenterol Res Pract       Date:  2009-08-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.